OTC Pharmaceuticals - Baltics | Statista Market Forecast

The revenue generated in the OTC Pharmaceuticals market in Baltics is estimated to be US$604.70m in 2024.
It is projected to experience an annual growth rate of 5.54% (CAGR 2024-2029).
Among the various markets, the largest one is Other OTC Pharmaceuticals, which is expected to reach a market volume of US$214.50m in 2024.
In comparison to other countries, the United States leads in terms of revenue generation, with an estimated amount of US$41.24bn in 2024.
Considering the population figures, the per person revenue in Baltics is predicted to be US$103.90 in 2024.
Furthermore, online sales are anticipated to contribute 3.91% of the total revenue in the OTC Pharmaceuticals market by 2024.
The OTC Pharmaceuticals market in the Baltics is experiencing a surge in demand for natural and herbal remedies.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Baltics is experiencing significant growth and development.

Customer preferences: Customers in the Baltics are increasingly seeking self-care options for their healthcare needs. They are looking for convenient and accessible solutions that do not require a prescription. The growing awareness of the benefits of OTC medications, such as cost-effectiveness and convenience, is driving the demand for these products. Customers also appreciate the wide range of options available in the OTC Pharmaceuticals market, allowing them to choose products that suit their specific needs.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in the Baltics is the increasing availability of OTC medications in pharmacies and supermarkets. This makes it easier for customers to access these products and encourages self-care. The market is also witnessing a shift towards natural and herbal remedies, as customers are becoming more conscious of their health and wellness. This trend is driven by the growing preference for products with fewer side effects and a more holistic approach to healthcare.Another trend in the market is the rising demand for OTC medications for specific conditions, such as allergies, pain relief, and digestive health. Customers are looking for targeted solutions that address their specific health concerns. This trend is supported by the increasing number of product offerings in these categories, as well as the growing awareness and education about these conditions.

Local special circumstances: The Baltics, comprising Estonia, Latvia, and Lithuania, have a well-developed healthcare system with a strong emphasis on primary care. This provides a solid foundation for the growth of the OTC Pharmaceuticals market, as customers are already accustomed to managing their healthcare needs through self-care. Additionally, the region has a high internet penetration rate, which allows customers to easily access information about OTC medications and make informed choices.

Underlying macroeconomic factors: The economic stability and increasing disposable income in the Baltics are contributing to the growth of the OTC Pharmaceuticals market. As customers have more purchasing power, they are willing to spend on healthcare products that offer convenience and self-care options. The region's aging population is also a factor driving the demand for OTC medications, as older adults often prefer self-care solutions for common ailments.In conclusion, the OTC Pharmaceuticals market in the Baltics is witnessing significant growth and development due to customer preferences for self-care options, the availability of a wide range of products, and the increasing demand for targeted solutions. The local healthcare system, high internet penetration rate, and favorable macroeconomic factors further support the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.